{
    "title": "Australia's CSL prices hemophilia gene therapy at $3.5 million",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11459009/FDA-approves-CSL-gene-therapy-hemophilia.html",
    "date": "2022-11-22",
    "keywords": [
        "gene",
        "price",
        "therapy",
        "csl",
        "stock",
        "leo",
        "roy",
        "hemophilia",
        "approval",
        "factor",
        "cost",
        "drug",
        "drugmaker",
        "ltd",
        "tuesday",
        "b",
        "treatment",
        "health",
        "regulator",
        "blood",
        "disorder",
        "solution",
        "biogen",
        "pfizer",
        "condition",
        "mutation",
        "bodys",
        "ability",
        "virus",
        "liver",
        "point",
        "healthcare",
        "system",
        "burden",
        "company",
        "list",
        "cowen",
        "analyst",
        "joseph",
        "thome",
        "note",
        "hemgenixs",
        "companys",
        "unit",
        "behring",
        "brand",
        "hemgenix",
        "food",
        "administration",
        "bio",
        "august",
        "zynteglo",
        "skysona",
        "investor",
        "zynteglos",
        "year",
        "uniqure",
        "milestone",
        "a30062",
        "exchange",
        "trading",
        "reporting",
        "leroy",
        "bengaluru",
        "editing",
        "kalluvila",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}